Heal and Soothe Promotes Natural Healing

Heal and Soothe uses the power of Systemic Enzyme Therapy to combat pain and inflammation. This type of therapy has been shown to be very effective and has even been used for over five decades in many countries throughout the world.

Systemic Enzyme Therapy puts biocatalysts to work throughout the body to help defend it form inflammation. They help to neutralize the biochemicals in the body so that it can heal and regenerate. By reducing inflammation, the body is able to recover much more quickly form fractures, sprains, joint pain, and surgery. Unlike pain medications, Heal and Soothe actually gets to the root of the problem and helps the body to recover rather than simply masking the pain and inflammation.

Heal and Soothe contains powerful and natural ingredients that work with the enzymes to promote healing and pain-free living. These ingredients include bromelain, proteolytic systemic enzymes, turmeric extract, papain, Boswellia extract. Heal and Soothe also contains rutin, Mojave yucca root, ginger extract, devil’s claw, and citrus bioflavonoids.

Citrus bioflavonoids help to heal the body from damage caused by oxidative damage. Devil’s claw is effective in treating pain and even helps to bring about relief from pain caused by arthritis. Ginger extract decreases the number of prostaglandins which cause the body to feel pain and Mojave yucca root is a powerful anti-inflammatory. Rutin is another powerful antioxidant, and Boswellia extract helps to support healthy blood circulation. Papain reduces swelling and pain, and turmeric has been found to destroy free radicals which contribute to pain and swelling. Bromelain helps to rid the body of waste and toxins, and proteolytic systemic enzymes boost cardiovascular, immune, and respiratory function.

Heal and Soothe is quite affordable at only around $50 a bottle and a bottle of supplements lasts about one month. Depending on the level of your pain and inflammation, you only need to take one supplement up to three times a day. Heal and Soothe does not have the unwanted and unpleasant side effects that many pain medications come with and it is completely natural, so that means that it is free from any animal byproducts as well.

Heal and Soothe is all about healing the body and strengthening it against pain and inflammation rather than simply numbing the pain and masking the inflammation. Heal and Soothe is a solution to the problem rather than just a band-aid that provides temporary relief from pain.

Heal N Soothe Info: www.youtube.com/watch?v=dbzLCWvD5tc

Eric Lefkofsky on ways technology can help doctors cure cancer

Doctors have new tools for fighting cancers. Cancer is a disease we know by one name, but which is really a wide variety of problems. Some cancers are primarily caused by a viral infection, or smoking, and some are due to a genetic roll of the dice. Each person is unique, and so is each cancer. Getting the medicine right, up until now was the purview of either a single specialist, or more recently, a team of specialists. They review the numbers, pore over the literature, and try to match surgery, radiation, chemotherapy and even nutrition to try to get the best outcome possible. The pace of medical information technology is increasing much quicker than people can catch up, and some are starting to recognize that we could do better.

This is where Tempus steps in to provide these specialized teams the information they need to build a treatment plan. In the medical world, the fax machine still reigns, and handwritten notes from physicians are transcribed, but present a challenge for computers. Scans and free-form text fields won’t submit to the clockwork machinery in simple computer programs, and some observations are lost without the ability to find them in disjoint systems across different offices.

Founder and CEO of Tempus Eric Lefkofsky is bringing technologies into the medical community to help with these problems, to bridge the gap with computers and new information technologies that can weed through data.

The technology used across silicon valley involves new challenges for these groups and Lefkofsky, former co-founder of Groupon, is no stranger to the niche issues of bringing technology to bear. He realized when starting Tempus that a bespoke treatment plan for one person may rely on something found in their genome sequencing, a vast amount of data that has only recently become available. Across this industry, there are few who doubt the potential in better information, even if it means making notes more searchable and durable. Tempus wants to “cutting-edge genomic sequencing and analysis methods,” which has the potential to save millions of lives.

Lefkofsky has an impressive history of thoughtful philanthropy, and since 2006 has operated the Lefkofsky Foundation for the “purpose of supporting charitable, scientific, and educational organizations and causes around the world”. He is seeing firsthand with Tempus how $1 million to the Robert H. Lurie Comprehensive Cancer Center of Northwestern University can impact real lives. They also gave $500,000 to fund gastric cancer research at Stanford University, and $1.2 million to University of Michigan for cancer research.

Lefkofsky has taught variously at DePaul University’s Kellstadt Graduate School of Business and at Northwestern University’s Kellogg School of Management. Currently, he is an adjunct professor at the University of Chicago’s Booth School of Business.

Learn More: lefkofskyfoundation.com/about-eric-lefkofsky/

Meet Dr. Mark Holterman, the Gifted Pediatric Surgeon

Dr. Mark J. Holterman is a renowned Pediatric surgeon, a university professor, philanthropist and entrepreneur. The gifted surgeon is full of obligation and commitment. Through extensive medical research, Dr. Mark is determined to succeed in regenerative medicine, cancer treatment, stem cell therapy and obesity. For over two decades Dr. Mark Holterman has voluntarily worked in numerous charity project, taught University medical students as well as launching the Mariam Global Health.

Volunteer Work

Based in Maywood, Illinois, Dr. Mark Holterman is regarded as children’s hero. He serves as the pediatric surgeon at the Children Hospital of Illinois and the Advocate Christ Children’s Hospital. At these children hospitals, the focus is clinical surgical care for infants and children. He has faithfully supported the International Pediatric Specialist Alliance for the Children of Vietnam (IPSAC-VN). Dr. Mark Holterman notable efforts for the organization have enabled the group advance the surgical procedures for children in Vietnam hospitals and medical schools. Read more about Dr. Mark Holterman at Dial Dish.

For the provision of their services, IPSAC-VN relies on donations and volunteers. The group volunteers who are qualified medical practitioners do train medical staffs and students in Vietnam as well as demonstrating new surgical techniques. Also, they perform Pediatric surgeries on children at the hospitals and medical schools. Furthermore, in furthering their childcare campaign, the charity group donate medical equipment to institutions in Vietnam.

About Mark

Dr. Mark Holterman attained his Bachelor’s degree in Arts, biology from Yale University. Later in 1980, he attended the University of Virginia for his doctorate in Medicine and Immunology. He began his career at the University of Virginia as the resident General Surgeon. From 1993, Dr. Holterman served at Seattle Children as the Fellowship in Pediatric Surgery as well as the instructor of surgery at the University of Washington. Learn more about Dr. Mark Holterman’s profile at healthgrove.com.

As a certified Pediatric surgeon, Dr. Mark has served as a full professor at the University of Illinois as well as attending to Rush University Medical Centre. In 2012, Dr. Mark Holterman founded the Mariam Global Health. This venture deals with global investment projects and management of firms targeting innovators. The company focuses on innovative businesses that aim at developing and implementing of scientific advances to make an impact on global health.

Visit: http://medicaldailytimes.com/medicine/dr-mark-holterman/2946/

Clay Siegall, Marketing Rights & The future if Seattle Genetics

Seattle Genetics is one of the most well-respected biotech companies in the world. The company specializes in the development and commercialization of antibody-based therapies. Dr. Clay Siegall is the president, the CEO and a co-founder of this extraordinary company. Seattle Genetics is one of the biggest employers in the Puget Sound area with over 900 employees. With its expected growth, another 250 individuals will be added to the roster in the near future. ADCETRIS, the company’s flagship drug, has brought in many hundreds of millions of dollars over the past few years, which has helped Seattle Genetics reach its $10 billion market value. The medication is being distributed across the globe in more than 65 countries. Siegall has stated that “we are an emerging global, oncology company.” The goal is to expand into international marketing instead of remaining in drug development.

Having international marketing rights means that you have full control of what your company introduces to the market. Unlike years of the past where Siegall was put into a predicament to sell his international rights to Takeda Oncology, he won’t be going that route ever again. The newer drugs that are in Seattle Genetics’ pipeline will retain their rights with the company. At this point, all of the capital that’s being generated will remain with Seattle Genetics instead of being distributed among company investors. Even if Siegall doesn’t go this route, the company would still be a huge success. In just the past five years, Seattle Genetics’ stock has tripled thanks to its powerful medications.

These medications are far more advanced than cancer fighting medications of the past because they can bind to cancer cells. When this happens, the medications will deliver a killing blow without harming any of the body’s good cells. These advanced therapies also benefits the patient by reducing any nasty side effects, which is highly associated with most cancer medications. The future of Seattle Genetics is looking brighter than ever before. Dr. Clay Siegall is all about evolving because if you don’t evolve, you’ll surely get left behind.